However, LDB2 has been shown to inhibit liver cancer cell proliferation and migration, functioning as a tumor suppressor [39], while ATF6 has been linked to the induction of intestinal dysbiosis and immune activity associated with the development of colorectal cancer [48]. Here, ATF6 is linked to liver cancer.